Similar articles

• The effect of subcapsular meningococcal B + C vaccine on the prognosis of patients with meningococcal disease.

  Barroso DE, Carvalho DM, Netto MA, Santos OH, Nascimento FA, Werneck GL. Barroso DE, et al. Scand J Infect Dis. 2002;34(6):417-20. doi: 10.1080/00365540110080322. Scand J Infect Dis. 2002. PMID: 12160167
• The current situation of meningococcal disease in Latin America and updated Global Meningococcal Initiative (GMI) recommendations.

  Sáfadi MA, O'Ryan M, Valenzuela Bravo MT, Brandileone MC, Gorla MC, de Lemos AP, Moreno G, Vazquez JA, López EL, Taha MK, Borrow R; Global Meningococcal Initiative. Sáfadi MA, et al. Vaccine. 2015 Nov 27;33(48):6529-36. doi: 10.1016/j.vaccine.2015.10.055. Epub 2015 Oct 25. Vaccine. 2015. PMID: 26597036 Review.
• [Meningococcal C conjugate vaccine: Impact of a vaccination program and long-term effectiveness in Navarra, Spain, 2000-2014].

  Morales D, García-Cenoz M, Moreno L, Bernaola E, Barricarte A, Castilla J. Morales D, et al. Enferm Infecc Microbiol Clin. 2016 Dec;34(10):639-644. doi: 10.1016/j.eimc.2015.11.020. Epub 2016 Jan 15. Enferm Infecc Microbiol Clin. 2016. PMID: 26778101 Spanish.
• [Meningococcal infections in Quebec, 1991-1992].

  [No authors listed] [No authors listed] Union Med Can. 1992 Nov-Dec;121(6):372-3. Union Med Can. 1992. PMID: 1481298 French. No abstract available.
• Modern trends in mortality from meningococcal disease in Australia.

  Simpkins D, Wood N, Jelfs J, McIntyre PB, Menzies R, Lawrence G, Booy R. Simpkins D, et al. Pediatr Infect Dis J. 2009 Dec;28(12):1119-20. doi: 10.1097/INF.0b013e3181accde8. Pediatr Infect Dis J. 2009. PMID: 19858774 Review.